Published in PLoS One on January 28, 2015
The quest for restoring hearing: Understanding ear development more completely. Bioessays (2015) 0.83
Advances in reprogramming-based study of neurologic disorders. Stem Cells Dev (2015) 0.76
Adult Stem Cells and Diabetes Therapy. J Stem Cell Res Transplant (2015) 0.76
Pluripotent stem cells for disease modeling and drug screening: new perspectives for treatment of cystic fibrosis? Mol Cell Pediatr (2015) 0.76
Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells. Int J Mol Sci (2016) 0.76
Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis. United European Gastroenterol J (2016) 0.75
Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery. PLoS One (2017) 0.75
Towards Organs on Demand: Breakthroughs and Challenges in Models of Organogenesis. Curr Pathobiol Rep (2016) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol (2006) 10.95
Generation of functional human pancreatic β cells in vitro. Cell (2014) 5.90
Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet (1997) 5.47
Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell (2011) 4.02
The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol (2008) 3.56
Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res (2002) 3.52
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol (2014) 3.20
Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes (2012) 2.40
A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One (2012) 2.24
Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med (2002) 2.20
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol (2009) 2.15
Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat Biotechnol (2011) 2.08
Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc (2010) 1.93
Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A (2010) 1.67
Immunological applications of stem cells in type 1 diabetes. Endocr Rev (2011) 1.20
Factors expressed by murine embryonic pancreatic mesenchyme enhance generation of insulin-producing cells from hESCs. Diabetes (2013) 1.08
Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes (2014) 1.04
ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One (2008) 0.99
HLA antigens in ocular tissues. I. In vivo expression in human eyes. Transplantation (1988) 0.90
The rise, fall, and resurgence of immunotherapy in type 1 diabetes. Pharmacol Res (2014) 0.89
Human iPS cell-derived hematopoietic progenitor cells induce T-cell anergy in in vitro-generated alloreactive CD8(+) T cells. Blood (2013) 0.85
PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice. Transplant Res (2012) 0.85
Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture. Sci Rep (2014) 0.85
Spontaneous in vivo differentiation of embryonic stem cell-derived pancreatic endoderm-like cells corrects hyperglycemia in diabetic mice. Transplantation (2011) 0.84
Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes. PLoS One (2014) 0.83
Evaluating insulin secretagogues in a humanized mouse model with functional human islets. Metabolism (2012) 0.83
Real-time non-invasive imaging of ES cell-derived insulin producing cells. Methods Mol Biol (2009) 0.79
Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice. Transplantation (2014) 0.78